Thanks funnyG986 for your post... I have been accumulating for a while now.
Are you able to elaborate more on this from 8k?
"On August 9, 2017, Medisun Precision Medicine Ltd. (the “Company”) entered into a settlement agreement (“Settlement”) with Zhengda Gene Life Science Shares Limited (“Zhengda”), a company incorporated in the Hong Kong Special Administrative Region of the People’s Republic of China (“PRC”), under which the Patent Assignment Agreement, dated July 7, 2017, between the Company and Zhengda was terminated. Pursuant to the Settlement, the Company assigned and transferred the Patent Rights back to Zhengda, while Zhengda returned the 15,000,000 Consideration Shares back to the Company. The foregoing descriptions are qualified in their entirety by reference to the Form of the Settlement which is filed herewith as Exhibit 10.1 to this Form 8-K and incorporated herein by reference."
I have tried reaching out to company but so far no results.
Thanks
